Search This Blog

Monday, 2 January 2017

BioPorto platform validated on Qiagen’s lateral flow system

BioPorto Diagnostics and Qiagen have validated BioPorto’s generic Rapid Assay Device (gRAD) lateral flow platform on Qiagen’s ESEQuant LR3 Lateral Flow System.



Read more about it via http://bit.ly/2hG24tM
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)